Histone-induced Thrombotic Thrombocytopenic Purpura in Zebrafish Depends on Von Willebrand Factor
Overview
Affiliations
Thrombotic thrombocytopenic purpura (TTP) is caused by severe deficiency of ADAMTS13 (A13), a plasma metalloprotease that cleaves endothelium-derived von Willebrand factor (VWF). However, severe A13 deficiency alone is often not sufficient to cause an acute TTP; additional factors may be required to trigger the disease. Using CRISPR/Cas9, we created and characterized several novel zebrafish lines carrying a null mutation in , , and both. We further used these zebrafish lines to test the hypothesis that inflammation that results in neutrophil activation and release of histone/DNA complexes may trigger TTP. As shown, zebrafish exhibit increased levels of plasma VWF antigen, multimer size, and ability of thrombocytes to adhere to a fibrillar collagen-coated surface under flow. The zebrafish also show an increased rate of occlusive thrombus formation in the caudal venules after FeCl injury. More interestingly, zebrafish exhibit ~30% reduction in the number of total, immature, and mature thrombocytes with increased fragmentation of erythrocytes. Administration of a lysine-rich histone results in more severe and persistent thrombocytopenia and a significantly increased mortality rate in zebrafish than in wildtype () ones. However, both spontaneous and histone-induced TTP in zebrafish are rescued by the deletion of These results demonstrate a potentially mechanistic link between inflammation and the onset of TTP in light of severe A13 deficiency; the novel zebrafish models of TTP may help accelerate our understanding of pathogenic mechanisms and the discoveries of novel therapeutics for TTP and perhaps other arterial thrombotic disorders.
Richter C, Raghunath A, Griffin M, Yaman M, Arruda V, Samelson-Jones B bioRxiv. 2025; .
PMID: 39896458 PMC: 11785011. DOI: 10.1101/2024.02.28.582609.
Sulforaphane Attenuates Ethanol-Induced Teratogenesis and Dysangiogenesis in Zebrafish Embryos.
Wu Z, Chen S, Zheng L Int J Mol Sci. 2024; 25(21).
PMID: 39519082 PMC: 11546994. DOI: 10.3390/ijms252111529.
Animal models for thrombotic thrombocytopenic purpura: a narrative review.
Zheng L, Zheng X Ann Blood. 2024; 8.
PMID: 39148951 PMC: 11326488. DOI: 10.21037/aob-22-18.
Falter T, Rossmann H, De Waele L, Dekimpe C, von Auer C, Muller-Calleja N Blood Adv. 2023; 7(17):5091-5102.
PMID: 37399489 PMC: 10471935. DOI: 10.1182/bloodadvances.2023010028.
Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?.
Cauchois R, Muller R, Lagarde M, Dignat-George F, Tellier E, Kaplanski G J Clin Med. 2023; 12(3).
PMID: 36769407 PMC: 9918301. DOI: 10.3390/jcm12030758.